Nura Bio: Funding, Investors & Team (Sep 2026)
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key role in axon degeneration. Nura Bio operates an integrated drug discovery platform that supports activities from target identification and validation through preclinical development. Its scientific efforts aim to address diseases affecting the peripheral, central, and ocular nervous systems.
Nura Bio has raised $73.8M across 1 funding round on record, the most recent a Series B of $73.8M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nura Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Nura Bio Funding Rounds
Nura Bio Founders and Leadership Team
Contact details for the Nura Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Nura Bio Funding Compared to Other Biotechnology Startups
Nura Bio's latest round of $73.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nura Bio in Biotechnology and South San Francisco
Companies Similar to Nura Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Nura Bio Funding FAQs
What does Nura Bio do?
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key role in axon degeneration. Nura Bio operates an integrated drug discovery platform that supports activities from target identification and validation through preclinical development. Its scientific efforts aim to address diseases affecting the peripheral, central, and ocular nervous systems.
How much funding has Nura Bio raised?
Nura Bio has raised $73.8M across 1 round on record. The most recent is a Series B of $73.8M announced in Jun 2026.
When did Nura Bio last raise funding?
Nura Bio's most recent funding round on record is a Series B of $73.8M, announced in Jun 2026.
Who founded Nura Bio?
FundedIQ lists Shilpa Sambashivan (Founder) at Nura Bio.
Where is Nura Bio headquartered?
Nura Bio is based in South San Francisco, California, United States.
How many employees does Nura Bio have?
Nura Bio is in the 11-50 employee band.
How does Nura Bio's funding compare to other Biotechnology startups?
Nura Bio's latest round of $73.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Nura Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nura Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.